Long-term outcome of repeated septal reduction therapy after
alcohol septal ablation for hypertrophic obstructive
cardiomyopathy: insight from the Euro-ASA registry

J 2020

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA et. al.

Základní údaje

Originální název

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

Autoři

VESELKA, Josef (203 Česká republika, garant), Lothar FABER (276 Německo), Max LIEBREGTS (528 Nizozemské království), Robert COOPER (826 Velká Británie a Severní Irsko), Jaroslav JANUSKA (203 Česká republika), Jan KREJČÍ (203 Česká republika, domácí), Maciej DABROWSKI (616 Polsko), Peter Riis HANSEN (208 Dánsko), Hubert SEGGEWISS (276 Německo), Dieter HORSTKOTTE (276 Německo), Eva HANSVENCLOVA (203 Česká republika), Henning BUNDGAARD (208 Dánsko), Jurrien TEN BERG (528 Nizozemské království) a Morten Kvistholm JENSEN (208 Dánsko)

Vydání

Archives of Medical Science, Poland, Termedia Publishing House, 2020, 1734-1922

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30218 General and internal medicine

Stát vydavatele

Polsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.318

Kód RIV

RIV/00216224:14110/20:00116377

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.5114/aoms.2020.97969

UT WoS

000559104100030

Klíčová slova anglicky

septal reduction therapy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy

Štítky

14110115, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 29. 10. 2020 13:21, Mgr. Tereza Miškechová

Anotace

V originále

Two-thirds of patients with hypertrophic cardiomyopathy (HCM) have a significant left ventricular outflow tract (LVOT) obstruction that may be treated with alcohol septal ablation (ASA) dependent on symptoms. However, some degree of obstruction may remain after ASA and if the patient remains symptomatic repeated septal reduction therapy (RSRT) may be indicated. The outcome of RSRT remains unknown. In this study, we sought to determine the long-term outcomes of patients treated with ASA or myectomy after previous ASA.

Citovat

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG a Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. Archives of Medical Science. Poland: Termedia Publishing House, 2020, roč. 16, č. 5, s. 1239-1242. ISSN 1734-1922. Dostupné z: https://dx.doi.org/10.5114/aoms.2020.97969.

@article{1677999,
   author = {Veselka, Josef and Faber, Lothar and Liebregts, Max and Cooper, Robert and Januska, Jaroslav and Krejčí, Jan and Dabrowski, Maciej and Hansen, Peter Riis and Seggewiss, Hubert and Horstkotte, Dieter and Hansvenclova, Eva and Bundgaard, Henning and ten Berg, Jurrien and Jensen, Morten Kvistholm},
   article_location = {Poland},
   article_number = {5},
   doi = {http://dx.doi.org/10.5114/aoms.2020.97969},
   keywords = {septal reduction therapy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy},
   language = {eng},
   issn = {1734-1922},
   journal = {Archives of Medical Science},
   title = {Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/},
   volume = {16},
   year = {2020}
}

TY  - JOUR
ID  - 1677999
AU  - Veselka, Josef - Faber, Lothar - Liebregts, Max - Cooper, Robert - Januska, Jaroslav - Krejčí, Jan - Dabrowski, Maciej - Hansen, Peter Riis - Seggewiss, Hubert - Horstkotte, Dieter - Hansvenclova, Eva - Bundgaard, Henning - ten Berg, Jurrien - Jensen, Morten Kvistholm
PY  - 2020
TI  - Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry
JF  - Archives of Medical Science
VL  - 16
IS  - 5
SP  - 1239-1242
EP  - 1239-1242
PB  - Termedia Publishing House
SN  - 17341922
KW  - septal reduction therapy
KW  - alcohol septal ablation
KW  - hypertrophic obstructive cardiomyopathy
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
L2  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
N2  - Two-thirds of patients with hypertrophic cardiomyopathy (HCM) have a significant left ventricular outflow tract (LVOT) obstruction that may be treated with alcohol septal ablation (ASA) dependent on symptoms. However, some degree of obstruction may remain after ASA and if the patient remains symptomatic repeated septal reduction therapy (RSRT) may be indicated. The outcome of RSRT remains unknown. In this study, we sought to determine the long-term outcomes of patients treated with ASA or myectomy after previous ASA.
ER  -

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG a Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. \textit{Archives of Medical Science}. Poland: Termedia Publishing House, 2020, roč.~16, č.~5, s.~1239-1242. ISSN~1734-1922. Dostupné z: https://dx.doi.org/10.5114/aoms.2020.97969.

Podrobný výpis o publikaci